SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the MicroThermX® Microwave Ablation System (MicroThermX®) was featured at the Company’s exhibition booth at the international meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), which was held in Munich, Germany, September 10-14, 2011. CIRSE is the world's largest and most comprehensive meeting dedicated to interventional radiology/oncology products. CIRSE focused on the latest, cutting-edge products in Interventional Radiology, and the MicroThermX® was showcased in the CIRSE exhibit space. BSD's senior sales and marketing managers had a number of strategic meetings with leading international distributors. Over 5,000 clinicians from 70 different countries around the world attended CIRSE, reflecting the global impact of the rapidly expanding field of interventional radiology. The global market for ablation treatments is expected to reach $2.0 billion.
